Accelerate Diagnostics, Inc. (AXDX)

Last Closing Price: 0.88 (2024-05-17)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Accelerate Diagnostics, Inc. (AXDX) had Net Income of $-61.62M for the most recently reported fiscal year, ending 2023-12-31.

Figures for fiscal year ending 2023-12-31
Income Statement Financials
$12.06M
Net Income
$-61.62M
$9.51M
$2.55M
$66.09M
$-54.03M
$-6.74M
$-60.77M
$-60.77M
$-61.62M
$-61.62M
$-61.62M
$-61.62M
$-54.03M
$-46.46M
12.48M
12.48M
$-4.94
$-4.94
Balance Sheet Financials
$24.47M
$2.39M
$6.90M
$31.37M
$12.03M
$36.36M
$39.22M
$51.25M
$-19.89M
$-19.89M
$-19.89M
14.57M
Cash Flow Statement Financials
$-40.20M
$8.66M
$9.02M
$34.91M
$12.14M
$-22.77M
$5.39M
--
--
Fundamental Metrics & Ratios
2.03
--
--
2.21
-1.89
21.15%
-448.03%
-448.03%
-385.30%
-503.92%
-510.97%
$-41.23M
--
--
--
0.38
2.87
4.60
79.36
309.82%
309.82%
-196.45%
-373.99%
$-1.36
$-3.30
$-3.22